Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold L Moses

Showing results (61-70 of 115) with videos related to

Pageof 12
Sort By:
Cancer Letters|August 4, 2015
Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growthLaura D Hover, Christian D Young, Neil E Bhola, et al.
Molecular and Cellular Biology|November 6, 2002
Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cellsBrian K Law, Anna Chytil, Nancy Dumont, et al.
Molecular Oncology|September 11, 2014
BMPR2 loss in fibroblasts promotes mammary carcinoma metastasis via increased inflammationMichael W Pickup, Laura D Hover, Eleanor R Polikowsky, et al.
The American Journal of Pathology|October 11, 2011
β-Catenin and K-RAS synergize to form primitive renal epithelial tumors with features of epithelial Wilms' tumorsPeter E Clark, Dina Polosukhina, Harold Love, et al.
The Journal of Urology|May 3, 2015
A Murine Model of K-RAS and β-Catenin Induced Renal Tumors Expresses High Levels of E2F1 and Resembles Human Wilms TumorYajun Yi, Dina Polosukhina, Harold D Love, et al.
Cancer Research|July 17, 2013
Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomasMichael W Pickup, Hanane Laklai, Irene Acerbi, et al.
The Journal of Clinical Investigation|May 20, 2009
Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancerBrian Bierie, Christine H Chung, Joel S Parker, et al.
Molecular and Cellular Biology|November 13, 2003
Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1Rebecca S Muraoka, Yasuhiro Koh, L Renee Roebuck, et al.
The Prostate|July 9, 2011
Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblastsShengqiang Yu, Chiuan-Ren Yeh, Yuanjie Niu, et al.
Cancer Research|July 17, 2004
Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancerSwati Biswas, Anna Chytil, Kay Washington, et al.
Pageof 12

Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
Cancer Letters|August 4, 2015
Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growthLaura D Hover, Christian D Young, Neil E Bhola, et al.
Molecular and Cellular Biology|November 6, 2002
Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cellsBrian K Law, Anna Chytil, Nancy Dumont, et al.
Molecular Oncology|September 11, 2014
BMPR2 loss in fibroblasts promotes mammary carcinoma metastasis via increased inflammationMichael W Pickup, Laura D Hover, Eleanor R Polikowsky, et al.
The American Journal of Pathology|October 11, 2011
β-Catenin and K-RAS synergize to form primitive renal epithelial tumors with features of epithelial Wilms' tumorsPeter E Clark, Dina Polosukhina, Harold Love, et al.
The Journal of Urology|May 3, 2015
A Murine Model of K-RAS and β-Catenin Induced Renal Tumors Expresses High Levels of E2F1 and Resembles Human Wilms TumorYajun Yi, Dina Polosukhina, Harold D Love, et al.
Cancer Research|July 17, 2013
Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomasMichael W Pickup, Hanane Laklai, Irene Acerbi, et al.
The Journal of Clinical Investigation|May 20, 2009
Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancerBrian Bierie, Christine H Chung, Joel S Parker, et al.
Molecular and Cellular Biology|November 13, 2003
Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1Rebecca S Muraoka, Yasuhiro Koh, L Renee Roebuck, et al.
The Prostate|July 9, 2011
Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblastsShengqiang Yu, Chiuan-Ren Yeh, Yuanjie Niu, et al.
Cancer Research|July 17, 2004
Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancerSwati Biswas, Anna Chytil, Kay Washington, et al.
Pageof 12